Katey Einterz Owen - Mar 4, 2025 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Katey Einterz Owen by Kyle Piskel, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Mar 4, 2025
Transactions value $
$0
Form type
4
Date filed
3/6/2025, 07:16 PM
Previous filing
Mar 6, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +15.4K +26.9% $0.00 72.6K Mar 4, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (right to buy) Award $0 +23.7K $0.00 23.7K Mar 4, 2025 Common Stock 23.7K $8.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates.